Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells

Radiotherapy and Oncology

Volumn 62, Issue 1, 2002, Pages 61-67

  Kim, Jae Sung ^a   Amorino, George P ^a   Pyo, Hongryull ^a   Cao, Qianwen ^a   Choy, Hak ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CPT 11; Etoposide; Lung cancer; Radiation; RFS 2000

Indexed keywords

7 AMINODACTINOMYCIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; IRINOTECAN; RUBITECAN;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL SURVIVAL; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; COMBINED MODALITY THERAPY; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENZYME INHIBITORS; ETOPOSIDE; HUMANS; LUNG NEOPLASMS; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0036159856     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00465-0     Document Type: Article

References (38)

1. Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer
2. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I
3. Posttreatment exposure to camptothecin enhances the lethal effects of X-rays on radioresistant human malignant melanoma cells
4. Mechanistic aspects of type-I topoisomerases
5. Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives
6. Irinotecan in combined modality therapy for locally advanced non-small cell lung cancer
7. DNA topoisomerases and DNA repair
8. Sequence effect of irinotecan (CPT-11) and topoisomerase II inhibitors in vivo
9. DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells
10. DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide
11. Assessing the interaction of irradiation with etoposide or idarubicin
12. Topoisomerase II: A specific marker for cell proliferation
13. DNA repair in radiation sensitive mutants of mammalian cells: Possible involvement of DNA topoisomerases
14. Etoposide enhances the lethal effect of radiation on breast cancer cells with less damage to mammary gland cells
15. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and a relation to antitumor activity
16. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I
17. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin
18. Action of camptothecin on mammalian cells in culture
19. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line
20. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864)
21. The interaction of etoposide with radiation: Variation in cytotoxicity with the sequence of treatment
22. The inhibition of cellular recovery in human tumor cells by inhibitors of topoisomerase
23. The scid defect results in much slower repair of DNA double-strand breaks but not high levels of residual breaks
24. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines
25. p53 status, cellular recovery and cell cycle arrest as prognosticators of in vitro radiosensitivity in human pancreatic adenocarcinoma cell lines
26. DNA topoisomerase I content of a pair of human melanoma cell lines with very different radiosensitivities correlates with their in vitro sensitivities to camptothecin
27. The use of 7-aminoactinomycin D in identifying apoptosis: Simplicity of use and broad spectrum of application compared with other techniques
28. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry
29. Effect of combined treatment with radiation and low dose etoposide on cell survival
30. X-ray and ultraviolet sensitivity of synchronized Chinese hamster cells at various stages of the cell cycle
31. Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts
32. Chemotherapy-radiation interactions in human cervix carcinoma xenografts
33. A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer
34. DNA topoisomerases: Why so many?
35. DNA topoisomerases
36. Topotecan increases topoisomerase IIalpha levels and sensitivity to treatment with etoposide in schedule-dependent process
37. P53 status plays no role in radiosensitizing effects of SN-38, a camptothecin derivative
38. DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells